Abstract
Objective: To determine midterm results of univentricular repair
using intra-atrial lateral tunnel at Queen Alia Heart Institute.
Methods: Between
January 1999 and January 2005, 159 patients (99 males, 60 females) underwent
either a fenestrated or non-fenestrated lateral tunnel (Fontan procedure), for
a wide range of complex congenital heart disease with a functional single
ventricle at Queen Alia Heart Institute. Median age at operation time was 3.8
years (range 1.5-17 years). Multiple factors were analyzed including:
anatomical variations, mean right atrial pressure, pulmonary artery pressure,
ventricular end diastolic pressure, aortic saturation, cardiopulmonary bypass time
and ischemic time, presence of arrhythmias, pacemaker insertion, thromboembolic
complications, early and late mortality.
Results: The major anatomic diagnosis was double inlet left
ventricle in 72 patients (45.3%) and the least was unbalanced complete atrioventricular
septal defect among 8 patients (5%). Dextrocardia was found in 17 patients. The
mean right atrial pressure was 8±3 mmHg, pulmonary artery pressure 13±2.6 mmHg,
PVR 1.9± 2 Woodunits.m2,
ventricular end diastolic pressure 14±2.2 mmHg, aortic saturation 83±4 %, cardiopulmonary
bypass time 121±9 minutes, ischemic time 47±3 minutes. Early postoperative
supraventricular tachyarrhythmia (SVT)
occurred among 10 cases (6.3%) of patients, in whom four needed antiarrhythmic
drugs before discharge. Early bradyarrhythmia needing pacemaker in 2 patients
(1.26%), whereas 6 patients needed pacemaker at mid term follow-up. There were
10 (6.3%) early deaths and no late deaths occurred after 6 years of follow-up.
Seven (4.7%) patients developed protein loosing enteropathy as a late
complication and 7 more patients (4.7%) developed neurological complications.
Conclusion: Proper selection of patients for the lateral
tunnel Fontan procedure results in excellent early and mid-term survival and
functional outcome with low incidence of complications.
Key words: Fontan
operation, Lateral tunnel, Single ventricle
JRMS
December 2009; 16(3):5-9
Introduction
Since the first successful
Fontan operation for tricuspid atresia that was performed in 1971,(1,2)
many modifications have been developed to optimize the early and long-term
outcomes of patients with complex cyanotic heart defects with afunctional single ventricle.(3,4) Since the intermediate and long-term results showed that the incorporation of the entire systemic venous atrium in the Fontan circulation was associated with a high incidence of supraventricular tachycardia (SVT) and thrombo-embolic complications,(2,5) more recent modifications have focused on the use of intra-atrial communication which was developed by de Leval and associates,(6) Jonas, and Castaneda.(7) The concept was to achieve a laminar blood flow in a tubular construct and to provide growth potential as well as a source for endothelializations of the synthetic surface.(8) This study was conducted to To determine midterm results of univentricular repair using intra-atrial lateral tunnel at Queen Alia Heart Institute (QAHI).
Table I. Major anatomic diagnoses
Double inlet left ventricle
|
72 patients
|
45.3%
|
Tricuspid atresia
|
63 patients
|
39.6%
|
Double outlet right ventricle with small LV
|
9 patients
|
5.7%
|
Pulmonary atresia with intact septum
|
8 patients
|
5%
|
Unbalanced complete atrioventricular septal defect
|
8 patients
|
5%
|
|
|
Table II. Preoperative demographic and hemodynamic data
Median age
|
3.8years (range17 months to 17 years)
|
Male to female ratio
|
1.65: 1
|
Mean pulmonary artery pressure
|
13 ± 2.6 mmHg
|
Mean pulmonary vascular resistance
|
1.9± 2mmHg
|
Mean right atrial pressure
|
8± 3mmHg
|
Mean ventricular end diastolic pressure
|
14± 2.2mmHg
|
Mean aortic saturation
|
83± 5%
|
Methods
Patients undergoing a total cavopulmonary
anastomosis with intra-atrial lateral tunnel at QAHI between January 1999 and
January 2005 for single ventricle physiology were identified from the filing of
the pediatric cardiology department. Patients
who underwent extra cardiac tunnel using Contegra were excluded. A total of 159 patients were included in this
study for whom the medical records were reviewed for patient personal data, symptoms,
echocardiography reports, cardiac catheterization reports, all available ECGs,
operative notes, pre- and post-operative hemodynamics. Ninety-nine patients
were males (62.3%) and sixty patients were females (37.7%) with a ratio of
1.65:1. The median age at the time of operation was 3.8 years (range 17 months
to 17 years). The major anatomic diagnosis was double inlet left ventricle in
72 patients (45.3%) and the least was unbalanced complete AV septal defect in 8
patients (5%) (see Table I).
Dextrocardia was found in 17
patients (10.7%). Eighteen patients (11.5%) had associated anomalies of
systemic venous return, whereas 7 patients (4.4%) had associated anomalies of
pulmonary venous return. None or trace AV valve regurgitation was present in
105 patients (66%), mild AV valve regurgitation in 51 patients (32%) and
moderate AV valve regurgitation in 3 patients (2%). One hundred thirty three
patients had previously undergone a palliative procedure, as it helps in
de-loading the ventricle, improving the pulmonary vascularity and the pulmonary
blood flow and improving the ventricular function; 55 of them had a previous
systemic pulmonary shunt, 43 patients had bi-directional Glenn shunt, 23
patients had pulmonary artery banding, and 12 patients had coarctation repair.
Preoperatively five patients had documented supraventricular tachycardia (SVT). Preoperative demographic and hemodynamic data
are shown in Table II.
Patients with increased
ventricular end diastolic pressure commonly had increased ventricular volume
load with preserved ventricular function. All Fontan (LT) operations were
performed via a median sternotomy and utilized cardiopulmonary bypass (CPB) and aortic cross clamping to ensure adequate
concomitant intracardiac procedures including atrio-ventricular (AV) valve
repair, anomalous pulmonary venous drainage and fenestration of the lateral
tunnel which was performed in 32 (20%) patients who met certain criteria.(9)
These criteria were elevated systolic pulmonary artery pressure > 20mmHg
and/ or PVR >2Wood units/m2,
abnormal pulmonary artery anatomy and significant AV valve regurgitation.
The fenestra was done using
2.5-4 mm coronary punch. The mean duration of CPB
time was 121± 9 minutes, whereas the mean aortic cross clamping time was 47±3
minutes. Postoperatively the mean CVP on the first day post operative was 13.9±
2.5mmHg (range 7- 25 mmHg). Postoperatively, the mean CVP on the first post
operative day was 13.9±2.5mmHg (range 7-25mmHg). Bilateral pleural chest tubes
and one pericardial were placed in all patients and were removed once they
drained < 2ml/kg/day for each tube. In the first 4 years of the study all
patients with fenestration were kept on acetylsalicylic acid (5mg/kg/d), but in
the last 2 years they were maintained on coumadin (warfarin) keeping their INR
between 2-2.5 as life long anticoagulant
in order to prevent thromboembolic complications.
Statistical Analysis:
Statistical analysis was performed using the CSS
software. All results were expressed as mean± standard deviation or median and
range. Variables comparing the mortality and the survival group were analyzed
using the paired student T test, and the statistical significance was defined
as P value < 0.05.
Early Results:
There were 10 (6.3%) early deaths that occurred in the
first 30 days post operatively. The preoperative diagnoses and the cause of
death are shown in table III. The most common cause for early death was
ventricular dysfunction in seven patients (70%). Significant pleural effusions
were drained for longer than 14 days in 28 patients. A total of 21 patients
(13.3%) had early postoperative arrhythmias. Ten patients (6.3%) had SVT and 4 of those were discharged on
antiarrhythmic medications. Nine patients (5.7%) had atrial junctional rhythm
with normal heart rate and 2 patients (5.7%) needed implantation of pacemaker
for atrioventricular dissociation before discharge. The rest of the patients (n=148,
93%) had documented normal sinus rhythm before discharge.
Mid-term Results:
The mean time of follow up
was 3.2 years with a range of 1.5-6.5 years, which is a relatively short period
of time for such an operation yet there were no intermediate deaths. The
fenestration closed spontaneously in 27 patients (84.3%). Neurological symptoms
were present in a total of 7 patients, in two of them hemiplegia developed at 5
and 18 months respectively and the other 5 had seizures after the Fontan (LT)
operation, all of them had open fenestrations, and were on aspirin. The two
patients with hemiplegia found to have protein C and S deficiency for that they
were maintained on warfarin. Protein loosing enteropathy with persistent or
recurrent edema, hypoproteinemia occurred in 7 patients (4.69%), who were
treated with parenteral albumin infusions, diuretics, and angiotensin-converting
enzyme inhibitors.
Five of them improved, whereas two patients improved after
creation of fenestra in the lateral tunnel. Other late reoperations or
reinterventions included embolization of systemic-pulmonary arterial
collaterals in 5 patients. ECGs recording during follow up were seen in one
hundred fourteen (76.5%) of patients, whereas Holter recordings were available
for thirty-eight patients (25.5%). SVT
was reported in thirteen (8.7%) patients during the follow-up period, 5 of them
had it preoperatively and 10 patients had the SVT
early post operatively.
Twelve patients (8.1%) had atrial junctional rhythm
with normal heart rate of which 9 had it early postoperatively. A pacemaker was
implanted during follow up period in 6 other patients (4%), for which the major
indication was documented symptomatic brady arrhythmia with heart rate less
than 50 beats/ minute. During midterm follow up, and according to New York
Heart Association’s (NYHA) functional classes, 141 patients (94.6%) were in
class I and II, 8 patients (5.4%) were in class III, 6 of which (75%) actually
did not undergo any palliative surgery, and no patients were in class IV.
Discussion
Many studies emphasize that results of Fontan
procedure are steadily improving over the past three decades,(3,4,10)
however there is considerable late morbidity that is evolving with the longer
follow up time. The absence of a ventricular pumping chamber for the pulmonary
circulation and the increase in systemic venous pressure are the main
haemodynamic features after Fontan procedure.(11)
Improvements in early survival are in part due to better selection of patients,(3,4)
patient preparation, optimizing staging of the Fontan procedures,(3,4,12)
and modifications of the Fontan operation, which included the LT and extra-cardiac
connections.(3,12)
Our study
demonstrates that our results in QAHI with the LT Fontan operation in term of
early and midterm complications are excellent and comparable with cardiac
centers across the world. The mortality rate in our study is low, and can be
attributed to the above mentioned reasons and the selective fenestration of the
baffle of the (LT) Fontan operation. The pre operative risk factors that increased
the early death or failure of the LT Fontan in our study included: Significant
elevation of the mean pulmonary artery pressure (PAP) of mortality
Table III. Causes of early mortality
Diagnosis
|
Mean PAP (mmHg)
|
Mean VEDP (mmHg)
|
Death history
|
1. DORV (small LV)
|
16
|
18
|
Ventricular dysfunction
|
2. DORV (small LV)
|
15
|
17
|
Ventricular dysfunction
|
3. DORV (small LV)
|
18
|
17
|
Ventricular dysfunction + (anomalous hepatic veins)
|
4.Unbalanced A-Vcanal (small LV)
|
18
|
20
|
Ventricular dysfunction (grade II AVVR)
|
5.DILV
|
15
|
15
|
Sepsis
|
6.Tricuspid Artesia
|
17
|
17
|
Sepsis
|
7.Pulmonary atresia & intact septum
|
20
|
18
|
Ventricular dysfunction
|
8.Unbalanced A-Vcanal (small LV)
|
15
|
17
|
Sepsis
|
9. DORV (small LV)
|
16
|
18
|
Ventricular dysfunction+(anomalous pulmonary veins)
|
10. Unbalanced A-Vcanal (small LV)
|
15
|
16
|
Ventricular dysfunction
(grade II AVVR)
|
DORV (double outlet right ventricle), DILV(double
inlet left ventricle), AVVR (atrio-ventricular
valve regurgitation), PAP( pulmonary artery pressure). VEDP (ventricular
end-diastolic pressure)cases 16.5±1.7mmHg, the mean ventricular end-diastolic
pressure (VEDP) 17±1.3mmHg with p <0.001.
Although the number of
patients with right ventricle morphology was relatively small (17 patients out
of 159), the death rate was 7 out the 17 patients (44%) which was significantly
higher than the mortality cases with left ventricular morphology (3 out of 132
patients) (1.88%) with a p=0.003. In our
analysis also we noticed that the longer stay on CPB
(127±4 vs. 121±9 minutes) p= <0.05, the longer the ischemic time (51± 5 vs.
47± 3) p=<0.05, the higher the risk of death or Fontan failure, in terms of
prolonged ventilatory support and prolonged stay in ICU as was confirmed by
many and most studies that were carried on Fontan procedure.(3)
Arrhythmias do occur due to
the distention of the atrium and the multiple suture lines.(13)
The incidence of arrhythmias in our study is comparable with other
studies ranging from 13.3 to 20.8%; 21 patients (13.3%) had arrhythmia at early
postoperative period and 31 (20.8%) patients had it at midterm follow-up, which
we believe can be explained by the awareness and meticulous repair of the
cardiac surgeons.
Our study had several
limitations including; the retrospective nature of the study, the
underestimation of the transient and intermittent arrhythmias, the limited
availability of serial Holter monitoring studies, the short duration of the
follow up mean of 3.2 years (range 2.8-5.1years).
Despite these limitations we
can still conclude that with good selection of patients, the ongoing
modifications in Fontan procedure, and the creation of fenestra when needed, provide
us with better outcomes. We advise to have more serial ECG, Holter monitoring
and electrophysiological studies for the patients. Long term follow up is still
warranted to better evaluate morbidity and mortality of LT Fontan operation.
References
1.
Burkhart
H, Dearani J, Mair D, et al. The modified Fontan procedure: Early and late results in 132 adult
patients. J Thorac Cardiovasc Surg
2003; 1252-1258
2.
Stamm
C, Frieh I, Mayer J, et al. Long-term results of the
lateral tunnel Fontan operation. J Thorac Cardiovasc Surg 2001; 121: 28-41
3.
Azakie
A, McCrindle B, Arsdell GV, et al. Extracardiac
conduit versus lateral tunnel cavopulmonary connections at a single
institution: Impact on outcomes. J Thorac Cardiovasc Surg 2001; 122:1219.
4.
Fontan
F, Kirklin JW, Fernandez G, et al. Oiutcome after a perfect Fontan operation. Circulation
1990; 81: 1520-1536.
5.
Gewilling
M, Wyse RK, de Leval MR, Deanfield JE. Early and late arrhythmias after the Fontan operation: predisposing
factors and clinical consequences. Br Heart J 1992; 67: 72-79.
6.
de
Leval MR, Kilner P, Gewilling M, Bull C. Total cavopulmonary connection: a logical alternative
to atriopulmonary connection for complex Fontan operations-experimental studies
and early clinical experience. J Thorac Cardiovasc Surg 1998; 96: 682-695.
7.
Jonas
RA, Castaneda AR. Modified
Fontan procedure: atrial baffle and systemic to pulmonary artery
anastomotictechniques. J Card Surg 1988; 3: 91-96.
8.
Kumar
SP, Rubinstein CS, Simsic JM, et al. Lateral tunnel versus Extracardiac conduit Fontan
procedure: A concurrent comparison. Elsevier Science Inc 2003.
9.
Airen
B, Sharma R, Choudhary SK, Smruti R. et al. Univentricular Repair: Is routine fenestration
justified. Elsiever Science Inc 2000.
10.
Mitchell
ME, Ittenbach RF, Gaynor JW, et al. Intermediate outcomes after the Fontan procedure in
the current era. J Thorac and
Cardiovas Surg 2006; 131:172-180.
11.
Kaulitz
R, Luhmer
I, Bergmann F, et al. Sequelae after
modified
Fontan
operation: postoperative haemodynamic
data and organ function. Heart 1997;
78: 154-159.
12.
Stamm
C, Friehs I, Mayer JE, et al. Long-term results of the lateral tunnel Fontan operation. J Thorac Cardiovasc Surg 2001; 121: 28-41.
13.
Bando
K, Turrentine MW, Park HJ, et al. Evolution of
the Fontan procedure in a single center. Elsiever Science Inc 2000.